TNF and Aicardi-Goutières syndrome: The type I IFN-regulated gene signature was increased to similar ranges as observed in a historical cohort of patients with Aicardi-Goutières syndrome (AGS), which persisted after start of treatment with TNF inhibitors (Fig. 1C).